Alkem Laboratories Limited Alkem Laboratories Limited

Alkem Laboratories Limited

ALKEM

Ранг среди акций #2839
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Цена акции
$55.51
Рыночная капитализация
$6.64B
Изменение (1 день)
0.52%
Изменение (1 год)
-11.92%
Страна
IN
Торговля Alkem Laboratories Limited (ALKEM)

Категория

Healthcare
EPS для Alkem Laboratories Limited (ALKEM)
EPS по состоянию на June 2026 TTM: $1.99
Согласно последним финансовым отчетам и цене акций Alkem Laboratories Limited, текущий EPS компании (TTM) составляет $1.99. В конце 2024 EPS компании составлял $1.80, больше, чем показателю 2023 года, равному $1.00.
История EPS компании Alkem Laboratories Limited с 2010 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $1.99 -6.17%
2025 $2.12 17.57%
2024 $1.80 79.83%
2023 $1.00 -44.76%
2022 $1.81 0.12%
2021 $1.81 44.74%
2020 $1.25 36.59%
2019 $0.92 13.02%
2018 $0.81 -29.55%
2017 $1.15 22.89%
2016 $0.94 78.39%
2015 $0.52 -14.30%
2014 $0.61 -19.80%
2013 $0.76 8.82%
2012 $0.70 15.60%
2011 $0.61 38.68%
2010 $0.44 0.00%
EPS для аналогичных компаний или конкурентов